Huadong Medicine Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Market Capitalization	59,995	69,031	60,553	72,565	82,087	70,342
Market Cap Growth	-7.09%	14.00%	-16.55%	-11.60%	16.70%	51.35%
Enterprise Value	58,775	67,298	58,711	70,923	81,583	69,341
Last Close Price	34.21	39.45	33.87	39.34	44.09	37.60
PE Ratio	17.13	20.22	17.24	25.56	32.85	30.56
Forward PE	13.40	18.98	19.83	27.57	30.39	29.34
PS Ratio	1.36	1.58	1.45	1.79	2.18	2.04
PB Ratio	2.30	2.74	2.57	3.36	4.28	4.15
P/TBV Ratio	3.16	3.81	3.67	4.50	5.92	5.76
P/FCF Ratio	19.82	25.84	29.96	31.24	69.06	29.92
P/OCF Ratio	14.20	16.26	16.15	18.47	34.46	22.19
PEG Ratio	1.46	1.27	1.27	1.27	1.27	1.27
EV/Sales Ratio	1.33	1.54	1.40	1.75	2.16	2.01
EV/EBITDA Ratio	11.38	13.34	11.50	16.43	21.60	20.91
EV/EBIT Ratio	14.29	16.33	13.53	19.76	25.86	24.71
EV/FCF Ratio	19.42	25.19	29.05	30.54	68.64	29.50
Debt / Equity Ratio	0.08	0.08	0.13	0.09	0.14	0.12
Debt / EBITDA Ratio	0.42	0.41	0.58	0.44	0.67	0.61
Debt / FCF Ratio	0.71	0.80	1.50	0.83	2.17	0.89
Net Debt / Equity Ratio	-0.06	-0.12	-0.09	-0.13	-0.07	-0.11
Net Debt / EBITDA Ratio	-0.31	-0.58	-0.44	-0.63	-0.37	-0.59
Net Debt / FCF Ratio	-0.52	-1.10	-1.11	-1.17	-1.19	-0.83
Asset Turnover	1.11	1.13	1.17	1.26	1.30	1.35
Inventory Turnover	5.75	5.72	6.18	6.25	6.07	5.96
Quick Ratio	1.21	1.15	1.15	1.28	1.23	1.21
Current Ratio	1.67	1.62	1.53	1.71	1.73	1.67
Return on Equity (ROE)	13.80%	14.00%	15.48%	13.97%	14.02%	14.56%
Return on Assets (ROA)	6.48%	6.70%	7.60%	6.94%	6.78%	6.85%
Return on Invested Capital (ROIC)	14.98%	16.07%	17.55%	16.10%	16.09%	16.02%
Return on Capital Employed (ROCE)	15.30%	15.90%	18.00%	15.80%	15.00%	15.80%
Earnings Yield	5.84%	4.95%	5.80%	3.91%	3.04%	3.27%
FCF Yield	5.05%	3.87%	3.34%	3.20%	1.45%	3.34%
Dividend Yield	2.64%	2.36%	2.75%	1.47%	0.66%	0.77%
Payout Ratio	48.88%	49.56%	48.47%	20.93%	23.07%	19.99%
Buyback Yield / Dilution	0.02%	-0.06%	-0.08%	-0.10%	-0.00%	0.00%
Total Shareholder Return	2.67%	2.30%	2.66%	1.37%	0.66%	0.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.